ASWINI S, BABU EZHUMALAI, HANUSHA V, and SETHUMEENA S. 2024. “A STUDY ON THE PREVALENCE OF ADVERSE EFFECTS ASSOCIATED WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN IN A TERTIARY CARE CENTRE”. Asian Journal of Pharmaceutical and Clinical Research 17 (12):147-50. https://doi.org/10.22159/ajpcr.2024v17i12.52456.